1-4 of 4
Yuelong Jiang
Close
Sort by
Journal Articles

Novel Therapeutic Combining CS055 with Chiglitazar Targets Leukemia Stem and Progenitor Cells in Acute Myeloid Leukemia

Hui Zhou, Dongmei Qin, Chendi Xie, Jie Zhou, Wenjuan Li, Mengya Zhong, Yuelong Jiang, Manman Deng, Haijun Zhao, Yong Zhou, Qian Lai, Zhihong Fang, Yiming Luo, Bing Xu, Jie Zha
Journal: Blood
Blood (2022) 140 (Supplement 1): 11731.
https://doi.org/10.1182/blood-2022-166807
Published: 2022
Journal Articles

Combination of CS2164 and Venetoclax Shows Synergistic Antitumor Effect in High-Grade B-Cell Lymphomas with Concomitant MYC and BCL2 Rearrangements

Manman Deng, MD PhD, Delin Yuan, MS, Genhong Li, MS, Yuelong Jiang, MS, Qinwei Chen, MD PhD, Zhihong Fang, MD PhD, Bing Xu, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 41.
https://doi.org/10.1182/blood-2020-140989
Published: 2020
Journal Articles

Low-Dose Triptolide Promotes MDM2 Inhibitor Nutlin3a to Induce Acute Myeloid Leukemia Cell Death Via p53-Dependent and -Independent Mechanisms

Qinwei Chen, MD PhD, Suqi Deng, MS, Zhijuan Lin, MD PhD, Manman Deng, MD PhD, Lihong Ding, MS, Jie Zha, MD PhD, Yong Zhou, MS, Yuelong Jiang, MS, Bing Z Carter, PhD, Bing Xu, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 24.
https://doi.org/10.1182/blood-2020-141315
Published: 2020
Journal Articles

Anlotinib Shows Potent Antileukemia Effects in B-Cell Acute Lymphocytic Leukemia through the Blockage of Angiogenic Related Pathways

Qiuling Chen, MS, Yuelong Jiang, MS, Qinwei Chen, MD PhD, Long Liu, MDPhD, Bing Xu, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 49.
https://doi.org/10.1182/blood-2020-141039
Published: 2020